ALEXANDRIA, Va., Jan. 13 -- United States Patent no. 12,521,396, issued on Jan. 13, was assigned to Kura Oncology Inc. (San Diego).
"Pharmaceutical compositions comprising a MENIN inhibitor" was invented by Jing Tao (San Diego), Roger Paul Bakale (San Diego), Craig Michael Bowe (San Diego), Dipanjan Sengupta (San Diego), Patricia Andres (Bend, Ore.) and Chaoyi Deng (Pudong New Area Shanghai, China).
According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are crystalline forms of (S)-4-methyl-5-((4-((2-(methylamino)-6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)methyl)-1-(2-(4-(methylsulfonyl)piperazin-1-yl)propyl)-1H-indole-2-carbonitrile or solvate thereof, methods of making...